Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
930studies shown
Showing 925-930 of 930
Drug study icon
CompletedNCT02050854

Safety study of pharmacokinetics of Aripiprazole in schizophrenia

This study is completed in the United States. It is testing pharmacokinetics of Aripiprazole for schizophrenia.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity, Schizophrenia
Device study icon
CompletedNCT03953417

Accelerated Theta Burst in Treatment-Resistant Depression in bipolarity

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 80 Years
Countries
United States
Sponsor
Stanford University
Condition
Depression, Bipolarity
Behavioral study icon
CompletedNCT00960375

Smoking Cessation for Veterans With Severe and Persistent Mental Illness

This study exists to compare options and see whether smoking support or smoking-related treatment offers something meaningfully different. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

Remote / online
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityBehavioralFrom 18 Years to 75 Years
Countries
United States
Sponsor
US Department of Veterans Affairs
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT01305408

Armodafinil Treatment (150 mg/Day) for depression

This study is completed in the United States, in Argentina, in Brazil, .... It is testing Armodafinil Treatment (150 mg/Day) for depression.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Cephalon
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01072630

Armodafinil Treatment for depression

This study is completed in the United States, in Australia, in France, .... It is testing armodafinil Treatment for depression.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Cephalon
Condition
Bipolarity, Depression
Biological study icon
CompletedNCT01385709

The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, Anxiety, ...OtherFrom 18 Years to 40 Years
Countries
United States
Sponsor
Weill Medical College of Cornell University
Condition
Depression, Anxiety, ...
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.